Memo Therapeutics
Series CMemo Therapeutics raised €26M in a Series C round in Nov 2023. The company is based in Zurich, Switzerland. Investors in the round: Adjuvant Capital, Fresenius Medical Care Ventures, GF Group Holding and 6 others. Data as of 4 Nov 2026.
Amount raised
€26M
€25,982,124
Native amount
25,000,000 CHF
Stage
Series C
series c
Investors
9
Provenance & confidence
High confidenceAmount
25,000,000 CHF
ECB-at-date → €26M · rate 0.9622 on 2023-11-02
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
9 namedAdjuvant CapitalFresenius Medical Care VenturesGF Group HoldingPureos BioventuresRedalpineSchroders CapitalSwisscanto InvestVerve VenturesVesalius Biocapital Partners
Date
Nov 2023
Round type
series c
Amount (EUR)
€26M